Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hematopoietic progenitor/stem cell compartment is a collection of multipotent and self-renewing cells within the bone marrow and, during development, extramedullary tissues. Hematopoietic stem cells (HSCs) within this compartment possess the ability to differentiate into all mature blood cell lineages and sustain lifelong blood production. Hematopoietic progenitor cells (HPCs) are downstream, committed to specific lineages and lack extensive self-renewal. This compartment is defined and studied by cell-surface markers (such as CD34, CD133, Sca-1, c-Kit, and absence of mature lineage markers), and is essential for hematopoietic homeostasis, transplantation, and therapy for hematologic diseases. The "Hematopoietic progenitor/stem cell compartment" is not a molecular target or receptor but a functionally defined group of cells. Its use as a therapeutic or biomarker target is indirect, with clinical interventions focusing on the entire cellular compartment rather than a discrete molecular entity.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hematopoietic stem and progenitor cell compartment (HSPC compartment).